NO157374C - Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-(2-(4,5,10,11-tetrahydro-1h-dibenzo(a,d)-cyklohepten-5-yl)etyl)-pyrrolidin. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-(2-(4,5,10,11-tetrahydro-1h-dibenzo(a,d)-cyklohepten-5-yl)etyl)-pyrrolidin.

Info

Publication number
NO157374C
NO157374C NO820125A NO820125A NO157374C NO 157374 C NO157374 C NO 157374C NO 820125 A NO820125 A NO 820125A NO 820125 A NO820125 A NO 820125A NO 157374 C NO157374 C NO 157374C
Authority
NO
Norway
Prior art keywords
cyclohepten
dibenzo
pyrrolidine
tetrahydro
ethyl
Prior art date
Application number
NO820125A
Other languages
English (en)
Norwegian (no)
Other versions
NO157374B (no
NO820125L (no
Inventor
Werner Aschwanden
Rudolf Pfister
Quirico Branca
Emilio Kyburz
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO820125L publication Critical patent/NO820125L/no
Publication of NO157374B publication Critical patent/NO157374B/no
Publication of NO157374C publication Critical patent/NO157374C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO820125A 1981-01-16 1982-01-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-(2-(4,5,10,11-tetrahydro-1h-dibenzo(a,d)-cyklohepten-5-yl)etyl)-pyrrolidin. NO157374C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH27381 1981-01-16

Publications (3)

Publication Number Publication Date
NO820125L NO820125L (no) 1982-07-19
NO157374B NO157374B (no) 1987-11-30
NO157374C true NO157374C (no) 1988-03-09

Family

ID=4183246

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820125A NO157374C (no) 1981-01-16 1982-01-15 Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-(2-(4,5,10,11-tetrahydro-1h-dibenzo(a,d)-cyklohepten-5-yl)etyl)-pyrrolidin.

Country Status (23)

Country Link
US (2) US4513002A (xx)
EP (1) EP0056617B1 (xx)
JP (1) JPS57139021A (xx)
KR (1) KR880001863B1 (xx)
AR (1) AR229877A1 (xx)
AT (1) ATE16484T1 (xx)
AU (1) AU550523B2 (xx)
CA (1) CA1157853A (xx)
DE (1) DE3267334D1 (xx)
DK (1) DK17982A (xx)
ES (2) ES8304557A1 (xx)
FI (1) FI76572C (xx)
GR (1) GR75161B (xx)
HU (1) HU184981B (xx)
IE (1) IE51955B1 (xx)
IL (1) IL64755A (xx)
MC (1) MC1439A1 (xx)
NO (1) NO157374C (xx)
NZ (1) NZ199451A (xx)
PH (1) PH17091A (xx)
PT (1) PT74287A (xx)
YU (1) YU6782A (xx)
ZA (1) ZA82136B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513002A (en) * 1981-01-16 1985-04-23 Hoffmann-La Roche Inc. Cycloheptene derivatives
US5049673A (en) * 1987-10-30 1991-09-17 The Regents Of The University Of California Fluorescent indicator dyes for calcium working at long wavelengths
US4920025A (en) * 1988-04-08 1990-04-24 Xerox Corporation Control of selenium alloy fractionation
US5223409A (en) * 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
ZA200804550B (en) 2005-11-09 2009-08-26 Combinatorx Inc Methods, compositions, and kits for the treatment of medical conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409640A (en) * 1959-07-22 1968-11-05 Schering Corp 5-(3'-dimethylamino-2'-methyl-propyl)dibenzocycloheptenes
GB1017696A (en) * 1961-09-25 1966-01-19 Merck & Co Inc Substituted 5h-dibenzo[a, d]cycloheptenes and 10,11-dihydro-5h-dibenzo[a, d]cycloheptenes
US3922305A (en) * 1962-08-09 1975-11-25 Merck & Co Inc Chemical compounds
US4136116A (en) * 1968-05-03 1979-01-23 Hoffmann-La Roche Inc. Tricyclic compounds
US4127717A (en) * 1978-03-20 1978-11-28 E. R. Squibb & Sons, Inc. Benzo-cyclitolamines
US4513002A (en) * 1981-01-16 1985-04-23 Hoffmann-La Roche Inc. Cycloheptene derivatives
US4337260A (en) * 1981-09-10 1982-06-29 Yoshitomi Pharmaceutical Industries, Ltd. Imidazopyridine-spiro-piperidine compounds

Also Published As

Publication number Publication date
KR830009021A (ko) 1983-12-17
ES508775A0 (es) 1983-03-16
IE820072L (en) 1982-07-16
ES8401760A1 (es) 1984-01-01
DK17982A (da) 1982-07-17
US4513002A (en) 1985-04-23
EP0056617A3 (en) 1982-11-17
AU550523B2 (en) 1986-03-27
AU7941882A (en) 1982-07-22
ATE16484T1 (de) 1985-11-15
KR880001863B1 (ko) 1988-09-23
ES517501A0 (es) 1984-01-01
AR229877A1 (es) 1983-12-30
DE3267334D1 (en) 1985-12-19
IE51955B1 (en) 1987-04-29
FI76572C (fi) 1988-11-10
IL64755A (en) 1985-04-30
FI76572B (fi) 1988-07-29
US4691040A (en) 1987-09-01
CA1157853A (en) 1983-11-29
ES8304557A1 (es) 1983-03-16
EP0056617A2 (de) 1982-07-28
FI820106L (fi) 1982-07-17
GR75161B (xx) 1984-07-13
MC1439A1 (fr) 1982-12-06
IL64755A0 (en) 1982-03-31
NO157374B (no) 1987-11-30
PH17091A (en) 1984-05-29
NO820125L (no) 1982-07-19
YU6782A (en) 1985-03-20
ZA82136B (en) 1982-11-24
NZ199451A (en) 1984-12-14
HU184981B (en) 1984-11-28
JPS57139021A (en) 1982-08-27
EP0056617B1 (de) 1985-11-13
PT74287A (en) 1982-02-01

Similar Documents

Publication Publication Date Title
NO159089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater.
NO148643C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 1-(1,3-dixolan-2-ylmetyl)-1h-imidazoler og-1h-1,2,4-triazoler
NO161065C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-azetidinoner.
DK154287A (da) Substituerede oxadiazol-derivater, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved fremgangsmaaden samt laegemiddel indeholdende oxadiazolerne
NO158419C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2-diaminocyklobuten-3,4-dioner.
NO810675L (no) Fremgangsmaate ved fremstilling av terapeutisk aktive tetrazolderivater.
NO156525C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive (3-aminopropoksy)bibenzylderivater.
NO165841C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater.
NO164472C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler.
NO159086C (no) Analogifremgangsmaate ved fremstilling av et terapeutisk aktivt triazolderivat.
NO154307C (no) Fremgangsmaate ved fremstilling av 1-(3-mercapto-(2s)-methylpropionyl)-pyrrolidin-(2s)-carboxylsyre.
NO165400C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser.
NO154268C (no) Analogifremgangsmaate ved fremstilling av nye terapeutisk aktive 6alfa-flour-9a-klor-prednisolon-17,21-diestere.
NO157538C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater.
NO159591C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt karbostyrilderivat.
NO157374C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktiv 1-(2-(4,5,10,11-tetrahydro-1h-dibenzo(a,d)-cyklohepten-5-yl)etyl)-pyrrolidin.
NO161313C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater.
NO155240C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl (propionyl- eller butyryl)-l-prolinderivater.
NO159793C (no) Analogifremgangsmaate for fremstilling av et terapeutisk aktivt 1-(4-arylcykloheksyl)-piperidinderivat.
NO163330C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater.
DK164364C (da) 4-(isoxazolyl)-thiazol-2-oxaminsyreforbindelser, en fremgangsmaade til fremstilling heraf, et mellemprodukt til brug ved fremgangsmaaden samt et farmaceutisk praeparat
NO881884L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO155054C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-amino-1-benzoxepin-5(2h)-derivater.
NO154795C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1,2,4-oxadiazolin-5-on-derivater.
NO154494C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorprostacykliner.